|
|
Article: U.S. Patent Disclosures.
- Article from:
- BIOWORLD Today
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Adherex Technologies Inc., of Ottawa, Ontario, was issued a U.S. patent for compounds that inhibit cancer metastasis via OB-cadherin (cadherin-11) antagonism.
Cepheid Inc., of Sunnyvale, Calif., was granted U.S. Patent No. 6,602,473, which covers aspects of the I-CORE heating system used in its Smart Cycler and GeneXpert systems for the rapid detection and assessment of genetic targets.
Cypress Bioscience Inc., of San Diego, was awarded U.S. Patent No. 6,602,911 covering methods of treating fibromyalgia syndrome with various dosages and formulations of milnacipran, a first-in-class, dual-acting reuptake inhibitor that acts on norepinephrine and ...